Abstract
Hemostasis is a physiological well-controlled complex process in the body in which the integrity of the circulatory system is maintained after vascular injury. This process consists of three main components: the vascular system, cellular components, and non-cellular components. These work together closely to keep the circulatory system in the best condition.
Hemostasis is divided into primary and secondary parts. In primary hemostasis, vascular endothelial cells and platelets initially form an unstable hemostatic platelet plug. Secondary hemostasis activates the coagulation cascade, resulting in formation of a stable fibrin clot. Overall, the goal of hemostasis is to stop bleeding from a site of injury. However, natural anticoagulants are necessary for limiting clot formation at the site, and the formed clot must be removed after healing to restore unimpeded blood flow. To achieve this, fibrinolysis is one of the most important processes, anticoagulants interacting in a complicated dance with pro-coagulants to limit vascular injury to the injured site.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Osaki T, Ichinose A. Current views of activating and regulatory mechanisms of blood coagulation. Nihon Rinsho Japanese J Clin Med. 2014;72(7):1206–11.
Davie EW. A brief historical review of the waterfall/cascade of blood coagulation. J Biol Chem. 2003;278(51):50819–32.
Butenas S, Mann K. Blood coagulation. Biochem Mosc. 2002;67(1):3–12.
Kasirer-Friede A, Shattil SJ. Regulation of platelet adhesion receptors. Platelets in thrombotic and non-thrombotic disorders. Springer; 2017. p. 69–84.
Feghhi S, Munday AD, Tooley WW, Rajsekar S, Fura AM, Kulman JD, et al. Glycoprotein Ib-IX-V complex transmits cytoskeletal forces that enhance platelet adhesion. Biophys J. 2016;111(3):601–8.
Bennett JS. Regulation of integrins in platelets. Pept Sci. 2015;104(4):323–33.
Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev. 2013;93(1):327–58.
Gremmel T, Frelinger AL III, Michelson AD. Platelet physiology. In: Seminars in thrombosis and hemostasis. Thieme Medical Publishers; 2016.
Sorrentino S, Studt J-D, Medalia O, Sapra KT. Roll, adhere, spread and contract: structural mechanics of platelet function. Eur J Cell Biol. 2015;94(3–4):129–38.
Goto S, Hasebe T, Takagi S. Platelets: small in size but essential in the regulation of vascular homeostasis–translation from basic science to clinical medicine. Circ J. 2015;79(9):1871–81.
Pryzdial EL, Lee FM, Lin BH, Carter RL, Tegegn TZ, Belletrutti MJ. Blood coagulation dissected. Transfus Apher Sci. 2018;57(4):449–57.
Dhar H, Santosh A. Glanzmann’s thrombasthenia: a review of literature. J South Asian Feder Obs Gynaecol. 2019;11(2):134–7.
Mohan G, Malayala SV, Mehta P, Balla M. A comprehensive review of congenital platelet disorders, thrombocytopenias and thrombocytopathies. Cureus. 2020;12(10):e11275.
Coller B. α II bβ3: structure and function. J Thromb Haemost. 2015;13:S17–25.
Bledzka K, Qin J, Plow EF. Integrin αIIbβ3. Platelets. 2019:227–41.
Quach ME, Li R. Structure-function of platelet glycoprotein Ib-IX. J Thromb Haemost. 2020;18(12):3131–41.
López JA. The platelet glycoprotein Ib-IX-V complex. Platelets in thrombotic and non-thrombotic disorders. Springer; 2017. p. 85–97.
Li R, Emsley J. The organizing principle of the platelet glycoprotein Ib–IX–V complex. J Thromb Haemost. 2013;11(4):605–14.
Almomani MH, Mangla A. Bernard Soulier syndrome. 2020.
Madamanchi A, Santoro SA, Zutter MM. α2β1 Integrin. I Domain Integrins. 2014;819:41–60.
Chastney MR, Conway JR, Ivaska J. Integrin adhesion complexes. Curr Biol. 2021;31(10):R536–R42.
Perrella G, Nagy M, Watson SP, Heemskerk JW. Platelet GPVI (Glycoprotein VI) and thrombotic complications in the venous system. Arterioscler Thromb Vasc Biol. 2021;41(11):2681–92.
Clark JC, Damaskinaki F-N, Cheung YFH, Slater A, Watson SP. Structure-function relationship of the platelet glycoprotein VI (GPVI) receptor: does it matter if it is a dimer or monomer? Platelets. 2021;32(6):724–32.
Arman M, Krauel K. Human platelet IgG Fc receptor Fcγ RIIA in immunity and thrombosis. J Thromb Haemost. 2015;13(6):893–908.
Gawaz M, Vogel S, Pfannenberg C, Pichler B, Langer H, Bigalke B. Implications of glycoprotein VI for theranostics. Thromb Haemost. 2014;112(07):26–31.
Kunicki TJ. Platelet membrane glycoproteins and their function: an overview. Blut. 1989;59(1):30–4.
Nurden AT, editor. Platelet membrane glycoproteins: a historical review. Seminars in thrombosis and hemostasis. Thieme Medical Publishers; 2014.
George JN. Platelet membrane glycoproteins. Springer Science & Business Media; 2013.
Flaumenhaft R, Sharda A. Platelet secretion. In: Platelets. Elsevier; 2019. p. 349–70.
Koseoglu S, Flaumenhaft R. Advances in platelet granule biology. Curr Opin Hematol. 2013;20(5):464–71.
Heijnen H, Van Der Sluijs P. Platelet secretory behaviour: as diverse as the granules… or not? J Thromb Haemost. 2015;13(12):2141–51.
Lang T, Johanning K, Metzler H, Piepenbrock S, Solomon C, Rahe-Meyer N, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg. 2009;108(3):751–8.
Sadeghian MH, Keramati MR, Badiei Z, Ravarian M, Ayatollahi H, Rafatpanah H, et al. Alloimmunization among transfusion-dependent thalassemia patients. Asian J Transfus Sci. 2009;3(2):95.
Yadav S, Storrie B. The cellular basis of platelet secretion: emerging structure/function relationships. Platelets. 2017;28(2):108–18.
Golebiewska EM, Poole AW. Platelet secretion: From haemostasis to wound healing and beyond. Blood Rev. 2015;29(3):153–62.
Millington-Burgess SL, Harper MT. Gene of the issue: ANO6 and Scott syndrome. Platelets. 2020;31(7):964–7.
Yau JW, Teoh H, Verma S. Endothelial cell control of thrombosis. BMC Cardiovasc Disord. 2015;15(1):1–11.
van Hinsbergh VW. Endothelium—role in regulation of coagulation and inflammation. In: Seminars in immunopathology. Springer; 2012.
Monahan-Earley R, Dvorak AM, Aird WC. Evolutionary origins of the blood vascular system and endothelium. J Thromb Haemost. 2013;11:46–66.
Neubauer K, Zieger B. Endothelial cells and coagulation. Cell Tissue Res. 2022;387(3):1–8.
Dekker RJ, van Thienen JV, Rohlena J, de Jager SC, Elderkamp YW, Seppen J, et al. Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. Am J Pathol. 2005;167(2):609–18.
Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res. 2007;100(2):174–90.
Bode M, Mackman N. Protective and pathological roles of tissue factor in the heart. Hamostaseologie. 2015;35(01):37–46.
Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med. 2011;364(18):1746–60.
Fetalvero KM, Martin KA, Hwa J. Cardioprotective prostacyclin signaling in vascular smooth muscle. Prostaglandins Other Lipid Mediat. 2007;82(1–4):109–18.
Schousboe I. Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor. Eur J Biochem. 2003;270(1):111–8.
Do H, Healey JF, Waller EK, Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells. J Biol Chem. 1999;274(28):19587–92.
Dubois C, Panicot-Dubois L, Gainor JF, Furie BC, Furie B. Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model. J Clin Invest. 2007;117(4):953–60.
Esmon CT, Esmon NL. The link between vascular features and thrombosis. Annu Rev Physiol. 2011;73:503–14.
Wood JP, Ellery PE, Maroney SA, Mast AE. Biology of tissue factor pathway inhibitor. Blood. 2014;123(19):2934–43.
Dahm A, van Hylckama VA, Bendz B, Rosendaal F, Bertina RM, Sandset PM. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. Blood. 2003;101(11):4387–92.
Collen D, Lijnen HR. The tissue-type plasminogen activator story. Arterioscler Thromb Vasc Biol. 2009;29(8):1151–5.
Chung DW, Fujikawa K. Processing of von Willebrand factor by ADAMTS-13. Biochemistry. 2002;41(37):11065–70.
Aird WC. Endothelium and hemostasis. Endothelial Cells Health Dis. 2005:450–63.
Petraglia AL, Marky AH, Walker C, Thiyagarajan M, Zlokovic BV. Activated protein C is neuroprotective and mediates new blood vessel formation and neurogenesis after controlled cortical impact. Neurosurgery. 2010;66(1):165–72.
Adams RL, Bird RJ. coagulation cascade and therapeutics update: relevance to nephrology. Part 1: Overview of coagulation, thrombophilias and history of anticoagulants. Nephrology. 2009;14(5):462–70.
Ramanan SV, Rajan J, Rajan S. The coagulation cascade. transfusion practice in clinical. Neurosciences. 2022:257.
O'Donnell JS, O'Sullivan JM, Preston RJ. Advances in understanding the molecular mechanisms that maintain normal haemostasis. Br J Haematol. 2019;186(1):24–36.
Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen L, et al. Role of tissue factor in embryonic blood vessel development. Nature. 1996;383(6595):73–5.
Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014;58(5):515.
Mann KG, Brummel-Ziedins K, Orfeo T, Butenas S. Models of blood coagulation. Blood Cell Mol Dis. 2006;36(2):108–17.
Grignani G, Maiolo A. Cytokines and hemostasis. Haematologica. 2000;85(9):967–72.
Mann KG, Butenas S, Brummel K. The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol. 2003;23(1):17–25.
Lasne D, Jude B, Susen S. From normal to pathological hemostasis. Can J Anesth. 2006;53(2):S2–S11.
Byrnes JR, Duval C, Wang Y, Hansen CE, Ahn B, Mooberry MJ, et al. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking. Blood. 2015;126(16):1940–8.
Weisel J, Litvinov R. Red blood cells: the forgotten player in hemostasis and thrombosis. J Thromb Haemost. 2019;17(2):271–82.
Gersh KC, Nagaswami C, Weisel JW. Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes. Thromb Haemost. 2009;102(12):1169–75.
Gillespie AH, Doctor A. Red blood cell contribution to hemostasis. Front Pediatr. 2021;9:629824.
Kujovich JL. Factor V Leiden Thrombophilia. 2018.
Pike RN, Buckle AM, le Bonniec BF, Church FC. Control of the coagulation system by serpins: getting by with a little help from glycosaminoglycans. FEBS J. 2005;272(19):4842–51.
Rigby AC, Grant MA. Protein S: a conduit between anticoagulation and inflammation. Crit Care Med. 2004;32(5):S336–S41.
Bos MH, Camire RM. A bipartite autoinhibitory region within the B-domain suppresses function in factor V. J Biol Chem. 2012;287(31):26342–51.
Mast AE. Tissue factor pathway inhibitor: multiple anticoagulant activities for a single protein. Arterioscler Thromb Vasc Biol. 2016;36(1):9–14.
Dahm A, Sandset P, Rosendaal F. The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1. J Thromb Haemost. 2008;6(2):393–5.
Corral J, González-Conejero R, Hernández-Espinosa D, Vicente V. Protein Z/Z-dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis. Br J Haematol. 2007;137(2):99–108.
Flemmig M, Melzig MF. Serine-proteases as plasminogen activators in terms of fibrinolysis. J Pharm Pharmacol. 2012;64(8):1025–39.
Rijken D, Lijnen H. New insights into the molecular mechanisms of the fibrinolytic system. J Thromb Haemost. 2009;7(1):4–13.
Dellas C, Loskutoff DJ. Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost. 2005;93(04):631–40.
Ezihe-Ejiofor JA, Hutchinson N. Anticlotting mechanisms 1: physiology and pathology. Contin Educ Anaesth Crit Care Pain. 2013;13(3):87–92.
Chapin JC, Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Rev. 2015;29(1):17–24.
Dorgalaleh A, Daneshi M, Rashidpanah J, Roshani YE. An overview of hemostasis. In: Dorgalaleh A, editor. Congenital bleeding disorders. Cham: Springer International Publishing; 2018. p. 3–26.
Marar T, Boffa M. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin. J Thromb Haemost. 2016;14(4):772–83.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Daneshi, M., Rashidpanah, J., Narouei, F. (2023). An Overview of Hemostasis. In: Dorgalaleh, A. (eds) Congenital Bleeding Disorders . Springer, Cham. https://doi.org/10.1007/978-3-031-43156-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-031-43156-2_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-43155-5
Online ISBN: 978-3-031-43156-2
eBook Packages: MedicineMedicine (R0)